Page 12 - Mark Kinarney News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation.
Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting
February 4, 2021 GMT
NORTH BILLERICA, Mass. (BUSINESS WIRE) Feb 4, 2021
Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, announced today three abstracts featuring its PSMA-targeted pipeline of product candidates have been selected for poster presentations at the upcoming 2021 American Society for Clinical Oncology Genitourinary (ASCO GU) Virtual Meeting, which will be held from February 11-13, 2021. Two of the abstracts relate to PyL™, the Company’s PET/CT imaging agent for prostate cancer, and the third ....

New York , United States , Memorial Sloan Kettering Cancer Center , New Jersey , North Billerica , Jeremyc Durack , Frederic Pouliot , Mark Kinarney , Oliver Sartor , Bausch Health Companies Inc , Centre Hospitalier Universitaire , Progenics Pharmaceuticals Inc , Tulane Cancer Center , Lantheus Medical Imaging Inc , Corporate Communications , Lantheus Holdings Inc , Lantheus Medical Imaging , Progenics Pharmaceuticals , Clinical Oncology Genitourinary , Virtual Meeting , Poster Session , Prostate Cancer , Advanced Disease , Progress Poster Session , Advanced Prostate Cancer , Lantheus Holdings ,